Laboratorios Farmaceuticos Rovi, S.A. Share Price Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.25 EUR | -1.17% |
|
+6.39% | -5.29% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 304.56Cr 346.6Cr 284.28Cr 260.9Cr 488.38Cr 33TCr 500.42Cr 3.37TCr 1.32TCr 16TCr 1.3TCr 1.27TCr 57TCr | P/E 2026 * |
21.3x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 302.94Cr 344.75Cr 282.77Cr 259.51Cr 485.78Cr 33TCr 497.76Cr 3.35TCr 1.31TCr 16TCr 1.29TCr 1.27TCr 56TCr | EV / Sales 2026 * |
3.93x | EV / Sales 2027 * | 3.33x |
| Free-Float |
31.63% | Yield 2026 * |
1.62% | Yield 2027 * | 1.96% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -1.08% | ||
| 1 week | +6.39% | ||
| Current month | +3.54% | ||
| 1 month | +2.13% | ||
| 3 months | -24.07% | ||
| 6 months | -17.65% | ||
| Current year | -5.29% |
| 1 week | 58.2 |  | 59.95 |
| 1 month | 53.15 | | 59.95 |
| Current year | 53.15 | | 86.6 |
| 1 year | 51.85 | | 86.6 |
| 3 years | 43.8 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | +6.39% | - | - | 346.6Cr | |
| -4.12% | -1.90% | +53.06% | +155.94% | 1,07900Cr | |
| -3.58% | -1.47% | +52.73% | +52.49% | 64TCr | |
| -2.80% | -0.47% | +35.08% | +70.96% | 47TCr | |
| -2.12% | +1.00% | +35.98% | +30.45% | 35TCr | |
| -2.14% | -0.61% | +33.53% | +39.32% | 30TCr | |
| -2.82% | +0.69% | +11.11% | +14.21% | 27TCr | |
| -2.15% | +3.22% | +1.72% | -39.46% | 23TCr | |
| -1.89% | +2.12% | +25.89% | +62.02% | 21TCr | |
| -2.71% | -1.31% | +12.53% | +69.62% | 16TCr | |
| Average | -2.58% | +3.22% | +29.07% | +50.62% | 41.22TCr | |
| Weighted average by Cap. | -3.11% | +3.63% | +38.00% | +74.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 88Cr 72Cr 66Cr 123.75Cr 8.41TCr 126.8Cr 854.15Cr 334.04Cr 4.16TCr 329.72Cr 322.57Cr 14TCr | 89Cr 101.38Cr 83Cr 76Cr 142.85Cr 9.71TCr 146.37Cr 985.99Cr 385.59Cr 4.8TCr 380.62Cr 372.35Cr 17TCr |
| Net income | 13Cr 15Cr 12Cr 11Cr 21Cr 1.4TCr 21Cr 142.28Cr 56Cr 693.35Cr 55Cr 54Cr 2.4TCr | 17Cr 20Cr 16Cr 15Cr 28Cr 1.9TCr 29Cr 192.47Cr 75Cr 937.95Cr 74Cr 73Cr 3.24TCr |
| Net Debt | -1.62Cr -1.85Cr -1.51Cr -1.39Cr -2.6Cr -176.74Cr -2.66Cr -18Cr -7.02Cr -87Cr -6.93Cr -6.78Cr -302.34Cr | -8.15Cr -9.28Cr -7.61Cr -6.98Cr -13Cr -888.48Cr -13Cr -90Cr -35Cr -439.66Cr -35Cr -34Cr -1.52TCr |
| Date | Price | Change |
|---|---|---|
| 29/26/29 | €59.95 | +1.01% |
| 28/26/28 | €59.35 | -0.17% |
| 27/26/27 | €59.45 | +0.59% |
| 24/26/24 | €59.10 | +0.68% |
| 23/26/23 | €58.70 | +4.17% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
